China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'GoGemDOx in the treatment of relapsed and refractory peripheral T-cell lymphoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135942
Registration Time: 2026/11/03
Type: Observational study
Primary Sponsor: Qilu Hospital of Shandong University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338879
Published by HT Digital Content Services with permission from Health Daily Digest....